Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 107 entries
Sorted by: Best Match Show Resources per page
Eliminating Piezoresistivity in Flexible Conducting Polymers for Accurate Temperature Sensing under Dynamic Mechanical Deformations.

Small (Weinheim an der Bergstrasse, Germany)

Sezen M, Register JT, Yao Y, Glisic B, Loo YL.
PMID: 27061270
Small. 2016 Jun;12(21):2832-8. doi: 10.1002/smll.201600858. Epub 2016 Apr 09.

The polarity and the magnitude of polyaniline's gauge factor are tuned through structural modification. Combining conducting polymers with gauge factors of opposite polarities yields an accurate temperature sensor, even when deployed under dynamic strains.

Cite
Sezen M, Register JT, Yao Y, et al. Eliminating Piezoresistivity in Flexible Conducting Polymers for Accurate Temperature Sensing under Dynamic Mechanical Deformations. Small. 2016;12(21):2832-8doi: 10.1002/smll.201600858.
Sezen, M., Register, J. T., Yao, Y., Glisic, B., & Loo, Y. L. (2016). Eliminating Piezoresistivity in Flexible Conducting Polymers for Accurate Temperature Sensing under Dynamic Mechanical Deformations. Small (Weinheim an der Bergstrasse, Germany), 12(21), 2832-8. https://doi.org/10.1002/smll.201600858
Sezen, Melda, et al. "Eliminating Piezoresistivity in Flexible Conducting Polymers for Accurate Temperature Sensing under Dynamic Mechanical Deformations." Small (Weinheim an der Bergstrasse, Germany) vol. 12,21 (2016): 2832-8. doi: https://doi.org/10.1002/smll.201600858
Sezen M, Register JT, Yao Y, Glisic B, Loo YL. Eliminating Piezoresistivity in Flexible Conducting Polymers for Accurate Temperature Sensing under Dynamic Mechanical Deformations. Small. 2016 Jun;12(21):2832-8. doi: 10.1002/smll.201600858. Epub 2016 Apr 09. PMID: 27061270.
Copy Download .nbib Format: NLM
Erratum to: Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture.

Archives of osteoporosis

Ferrari S, Reginster JY, Brandi ML, Kanis JA, Devogelaer JP, Kaufman JM, Féron JM, Kurth A, Rizzoli R.
PMID: 28255680
Arch Osteoporos. 2017 Dec;12(1):25. doi: 10.1007/s11657-017-0319-2.

No abstract available.

Cite
Ferrari S, Reginster JY, Brandi ML, et al. Erratum to: Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture. Arch Osteoporos. 2017;12(1):25doi: 10.1007/s11657-017-0319-2.
Ferrari, S., Reginster, J. Y., Brandi, M. L., Kanis, J. A., Devogelaer, J. P., Kaufman, J. M., Féron, J. M., Kurth, A., & Rizzoli, R. (2017). Erratum to: Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture. Archives of osteoporosis, 12(1), 25. https://doi.org/10.1007/s11657-017-0319-2
Ferrari, Serge, et al. "Erratum to: Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture." Archives of osteoporosis vol. 12,1 (2017): 25. doi: https://doi.org/10.1007/s11657-017-0319-2
Ferrari S, Reginster JY, Brandi ML, Kanis JA, Devogelaer JP, Kaufman JM, Féron JM, Kurth A, Rizzoli R. Erratum to: Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture. Arch Osteoporos. 2017 Dec;12(1):25. doi: 10.1007/s11657-017-0319-2. PMID: 28255680; PMCID: PMC6828340.
Copy Download .nbib Format: NLM
Macro-economic factors influencing the architectural business model shift in the pharmaceutical industry.

Expert review of pharmacoeconomics & outcomes research

Dierks RM, Bruyère O, Reginster JY, Richy FF.
PMID: 27653356
Expert Rev Pharmacoecon Outcomes Res. 2016 Oct;16(5):571-578. doi: 10.1080/14737167.2016.1239534. Epub 2016 Oct 04.

INTRODUCTION: Technological innovations, new regulations, increasing costs of drug productions and new demands are only few key drivers of a projected alternation in the pharmaceutical industry. The purpose of this review is to understand the macro economic factors responsible...

Cite
Dierks RM, Bruyère O, Reginster JY, et al. Macro-economic factors influencing the architectural business model shift in the pharmaceutical industry. Expert Rev Pharmacoecon Outcomes Res. 2016;16(5):571-578doi: 10.1080/14737167.2016.1239534.
Dierks, R. M., Bruyère, O., Reginster, J. Y., & Richy, F. F. (2016). Macro-economic factors influencing the architectural business model shift in the pharmaceutical industry. Expert review of pharmacoeconomics & outcomes research, 16(5), 571-578. https://doi.org/10.1080/14737167.2016.1239534
Dierks, Raphaela Marie Louisa, et al. "Macro-economic factors influencing the architectural business model shift in the pharmaceutical industry." Expert review of pharmacoeconomics & outcomes research vol. 16,5 (2016): 571-578. doi: https://doi.org/10.1080/14737167.2016.1239534
Dierks RM, Bruyère O, Reginster JY, Richy FF. Macro-economic factors influencing the architectural business model shift in the pharmaceutical industry. Expert Rev Pharmacoecon Outcomes Res. 2016 Oct;16(5):571-578. doi: 10.1080/14737167.2016.1239534. Epub 2016 Oct 04. PMID: 27653356.
Copy Download .nbib Format: NLM
Mobile Phone-Connected Wearable Motion Sensors to Assess Postoperative Mobilization.

JMIR mHealth and uHealth

Appelboom G, Taylor BE, Bruce E, Bassile CC, Malakidis C, Yang A, Youngerman B, D'Amico R, Bruce S, Bruyère O, Reginster JY, Dumont EP, Connolly ES.
PMID: 26220691
JMIR Mhealth Uhealth. 2015 Jul 28;3(3):e78. doi: 10.2196/mhealth.3785.

BACKGROUND: Early mobilization after surgery reduces the incidence of a wide range of complications. Wearable motion sensors measure movements over time and transmit this data wirelessly, which has the potential to monitor patient recovery and encourages patients to engage...

Cite
Appelboom G, Taylor BE, Bruce E, et al. Mobile Phone-Connected Wearable Motion Sensors to Assess Postoperative Mobilization. JMIR Mhealth Uhealth. 2015;3(3):e78doi: 10.2196/mhealth.3785.
Appelboom, G., Taylor, B. E., Bruce, E., Bassile, C. C., Malakidis, C., Yang, A., Youngerman, B., D'Amico, R., Bruce, S., Bruyère, O., Reginster, J. Y., Dumont, E. P., & Connolly, E. S. (2015). Mobile Phone-Connected Wearable Motion Sensors to Assess Postoperative Mobilization. JMIR mHealth and uHealth, 3(3), e78. https://doi.org/10.2196/mhealth.3785
Appelboom, Geoff, et al. "Mobile Phone-Connected Wearable Motion Sensors to Assess Postoperative Mobilization." JMIR mHealth and uHealth vol. 3,3 (2015): e78. doi: https://doi.org/10.2196/mhealth.3785
Appelboom G, Taylor BE, Bruce E, Bassile CC, Malakidis C, Yang A, Youngerman B, D'Amico R, Bruce S, Bruyère O, Reginster JY, Dumont EP, Connolly ES. Mobile Phone-Connected Wearable Motion Sensors to Assess Postoperative Mobilization. JMIR Mhealth Uhealth. 2015 Jul 28;3(3):e78. doi: 10.2196/mhealth.3785. PMID: 26220691; PMCID: PMC4705357.
Copy Download .nbib Format: NLM
[Antituberculotic chemotherapy].

Revue medicale de Liege

REGINSTER A.
PMID: 13290411
Rev Med Liege. 1955 Oct 01;10(19):567-73; contd.

No abstract available.

Cite
REGINSTER A. La chimiothérapie antituberculeuse. [Antituberculotic chemotherapy]. Rev Med Liege. 1955;10(19):567-73; contd
REGINSTER, A. (1955). La chimiothérapie antituberculeuse. [Antituberculotic chemotherapy]. Revue medicale de Liege, 10(19), 567-73; contd.
REGINSTER, A. "La chimiothérapie antituberculeuse." [Antituberculotic chemotherapy]. Revue medicale de Liege vol. 10,19 (1955): 567-73; contd.
REGINSTER A. La chimiothérapie antituberculeuse. [Antituberculotic chemotherapy]. Rev Med Liege. 1955 Oct 01;10(19):567-73; contd. French. PMID: 13290411.
Copy Download .nbib Format: NLM
[Detection of preclinical tuberculosis].

Revue medicale de Liege

REGINSTER A.
PMID: 13290429
Rev Med Liege. 1955 Dec 15;10(24):719-23.

No abstract available.

Cite
REGINSTER A. Dépistage de la tuberculose préclinique. [Detection of preclinical tuberculosis]. Rev Med Liege. 1955;10(24):719-23
REGINSTER, A. (1955). Dépistage de la tuberculose préclinique. [Detection of preclinical tuberculosis]. Revue medicale de Liege, 10(24), 719-23.
REGINSTER, A. "Dépistage de la tuberculose préclinique." [Detection of preclinical tuberculosis]. Revue medicale de Liege vol. 10,24 (1955): 719-23.
REGINSTER A. Dépistage de la tuberculose préclinique. [Detection of preclinical tuberculosis]. Rev Med Liege. 1955 Dec 15;10(24):719-23. French. PMID: 13290429.
Copy Download .nbib Format: NLM
Anti-tuberculosis chemotherapy.

Revue medicale de Liege

REGINSTER A.
PMID: 13267254
Rev Med Liege. 1955 Sep 15;10(18):538-42; contd.

No abstract available.

Cite
REGINSTER A. La chimiothérapie antituberculeuse. Anti-tuberculosis chemotherapy. Rev Med Liege. 1955;10(18):538-42; contd
REGINSTER, A. (1955). La chimiothérapie antituberculeuse. Anti-tuberculosis chemotherapy. Revue medicale de Liege, 10(18), 538-42; contd.
REGINSTER, A. "La chimiothérapie antituberculeuse." Anti-tuberculosis chemotherapy. Revue medicale de Liege vol. 10,18 (1955): 538-42; contd.
REGINSTER A. La chimiothérapie antituberculeuse. Anti-tuberculosis chemotherapy. Rev Med Liege. 1955 Sep 15;10(18):538-42; contd. French. PMID: 13267254.
Copy Download .nbib Format: NLM
[In Process Citation].

Journal de pharmacie de Belgique

Reginster JY, Halkin V.
PMID: 11098589
J Pharm Belg. 2000 Sep;55(5):118-21.

No abstract available.

Cite
Reginster JY, Halkin V. Les proprietes de la glucosamine. [In Process Citation]. J Pharm Belg. 2000;55(5):118-21
Reginster, J. Y., & Halkin, V. (2000). Les proprietes de la glucosamine. [In Process Citation]. Journal de pharmacie de Belgique, 55(5), 118-21.
Reginster, and Halkin. "Les proprietes de la glucosamine." [In Process Citation]. Journal de pharmacie de Belgique vol. 55,5 (2000): 118-21.
Reginster JY, Halkin V. Les proprietes de la glucosamine. [In Process Citation]. J Pharm Belg. 2000 Sep;55(5):118-21. French. PMID: 11098589.
Copy Download .nbib Format: NLM
Relevance of bone mineral density, bone quality and falls in reduction of vertebral and non-vertebral fractures.

Journal of musculoskeletal & neuronal interactions

Hanssens L, Reginster JY.
PMID: 15758340
J Musculoskelet Neuronal Interact. 2003 Sep;3(3):189-93.

All epidemiological studies conclude that without prompt, concerted and well-designed prevention programs, the increasing cost related to osteoporotic fractures will become an unbearable burden for the community within the next fifteen years. However, the most effective way of setting...

Cite
Hanssens L, Reginster JY. Relevance of bone mineral density, bone quality and falls in reduction of vertebral and non-vertebral fractures. J Musculoskelet Neuronal Interact. 2003;3(3):189-93
Hanssens, L., & Reginster, J. Y. (2003). Relevance of bone mineral density, bone quality and falls in reduction of vertebral and non-vertebral fractures. Journal of musculoskeletal & neuronal interactions, 3(3), 189-93.
Hanssens, L, and Reginster, J Y. "Relevance of bone mineral density, bone quality and falls in reduction of vertebral and non-vertebral fractures." Journal of musculoskeletal & neuronal interactions vol. 3,3 (2003): 189-93.
Hanssens L, Reginster JY. Relevance of bone mineral density, bone quality and falls in reduction of vertebral and non-vertebral fractures. J Musculoskelet Neuronal Interact. 2003 Sep;3(3):189-93. PMID: 15758340.
Copy Download .nbib Format: NLM
The current orientation of tuberculosis control in the United States; Antibiotics in the treatment of tuberculosis.

Revue medicale de Liege

REGINSTER A.
PMID: 20263779
Rev Med Liege. 1947 May 15;2(10):262-5.

No abstract available.

Cite
REGINSTER A. L'orientation actuelle de la lutte antituberculeuse aux Etats-Unis; les antibiotiques dans le traitement de la tuberculose. The current orientation of tuberculosis control in the United States; Antibiotics in the treatment of tuberculosis. Rev Med Liege. 1947;2(10):262-5
REGINSTER, A. (1947). L'orientation actuelle de la lutte antituberculeuse aux Etats-Unis; les antibiotiques dans le traitement de la tuberculose. The current orientation of tuberculosis control in the United States; Antibiotics in the treatment of tuberculosis. Revue medicale de Liege, 2(10), 262-5.
REGINSTER, A. "L'orientation actuelle de la lutte antituberculeuse aux Etats-Unis; les antibiotiques dans le traitement de la tuberculose." The current orientation of tuberculosis control in the United States; Antibiotics in the treatment of tuberculosis. Revue medicale de Liege vol. 2,10 (1947): 262-5.
REGINSTER A. L'orientation actuelle de la lutte antituberculeuse aux Etats-Unis; les antibiotiques dans le traitement de la tuberculose. The current orientation of tuberculosis control in the United States; Antibiotics in the treatment of tuberculosis. Rev Med Liege. 1947 May 15;2(10):262-5. French. PMID: 20263779.
Copy Download .nbib Format: NLM
Efficacy and tolerability of calcitonin in the prevention and treatment of osteoporosis.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Halkin V, Reginster JY.
PMID: 18020602
BioDrugs. 1998 Oct;10(4):295-300. doi: 10.2165/00063030-199810040-00004.

Calcitonin in general, and, more specifically, salmon calcitonin (salcatonin), has been known for 30 years to be a specific inhibitor of bone resorption. Studies have confirmed its efficacy in metabolic bone diseases characterised by excessive bone resorption, such as...

Cite
Halkin V, Reginster JY. Efficacy and tolerability of calcitonin in the prevention and treatment of osteoporosis. BioDrugs. 1998;10(4):295-300doi: 10.2165/00063030-199810040-00004.
Halkin, V., & Reginster, J. Y. (1998). Efficacy and tolerability of calcitonin in the prevention and treatment of osteoporosis. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 10(4), 295-300. https://doi.org/10.2165/00063030-199810040-00004
Halkin, V, and Reginster, J Y. "Efficacy and tolerability of calcitonin in the prevention and treatment of osteoporosis." BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy vol. 10,4 (1998): 295-300. doi: https://doi.org/10.2165/00063030-199810040-00004
Halkin V, Reginster JY. Efficacy and tolerability of calcitonin in the prevention and treatment of osteoporosis. BioDrugs. 1998 Oct;10(4):295-300. doi: 10.2165/00063030-199810040-00004. PMID: 18020602.
Copy Download .nbib Format: NLM
Smouldering malignant melanoma and metastatic dormancy: an update and review.

Dermatology research and practice

Piérard GE, Piérard-Franchimont C, Reginster MA, Quatresooz P.
PMID: 22110487
Dermatol Res Pract. 2012;2012:461278. doi: 10.1155/2012/461278. Epub 2011 Nov 02.

The fund of knowledge regarding the versatility of presentation of MM metastases is still quite incomplete. The recent literature pertaining to the current understanding of the mechanisms underlying two special features of MM metastasis is reviewed. On the one...

Cite
Piérard GE, Piérard-Franchimont C, Reginster MA, et al. Smouldering malignant melanoma and metastatic dormancy: an update and review. Dermatol Res Pract. 2011;2012:461278doi: 10.1155/2012/461278.
Piérard, G. E., Piérard-Franchimont, C., Reginster, M. A., & Quatresooz, P. (2012). Smouldering malignant melanoma and metastatic dormancy: an update and review. Dermatology research and practice, 2012461278. https://doi.org/10.1155/2012/461278
Piérard, Gérald E, et al. "Smouldering malignant melanoma and metastatic dormancy: an update and review." Dermatology research and practice vol. 2012 (2012): 461278. doi: https://doi.org/10.1155/2012/461278
Piérard GE, Piérard-Franchimont C, Reginster MA, Quatresooz P. Smouldering malignant melanoma and metastatic dormancy: an update and review. Dermatol Res Pract. 2012;2012:461278. doi: 10.1155/2012/461278. Epub 2011 Nov 02. PMID: 22110487; PMCID: PMC3216350.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 107 entries